Agilon Health, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $1.74B
  • PE -7
  • Debt $34.90M
  • Cash $193.86M
  • EV $1.58B
  • FCF -$71.03M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$260.15M
EBIT-$248.83M
ROE-55%
ROA-14%
FCF-$71.03M
Equity$470.95M
Growth Stability1
PE-6.69
PB3.7
P/FCF-24.5
P/S0.29
Price/Cash0.11
Debt/Equity0.07
Debt/FCF-0.49
Net Margins-4%
Op. Margins-4%
Sales Growth YoY87%
Sales Growth QoQ5%
Sales CAGR50%
Equity CAGR-19%
Earnings Growth YoY-54%
Earnings Growth QoQ-10%
Sales CAGR 5Y50%
Equity CAGR 5Y-20%
Earnings CAGR 3Y49%
Sales CAGR 3Y49%
Equity CAGR 3Y-27%
Market Cap$1.74B
Revenue$6.06B
Assets$1.73B
Total Debt$34.90M
Cash$193.86M
Shares Outstanding410.97M
EV1.58B
Moat Score7%
Safety Score65%
Working Capital305.77M
Current Ratio1.27
Shares Growth 3y1%
Equity Growth QoQ-18%
Equity Growth YoY-29%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

SEC Filings

Direct access to Agilon Health, Inc. (AGL) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Agilon Health, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Agilon Health, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Agilon Health, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Agilon Health, Inc..

= -$710M
012345678910TV
fcf-$71M-$71M-$71M-$71M-$71M-$71M-$71M-$71M-$71M-$71M-$71M-$710M
DCF-$65M-$59M-$53M-$49M-$44M-$40M-$36M-$33M-$30M-$27M-$274M
Value-$710M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201912/202012/202112/202212/202312/2024TTM
Net Margins-36%-5%-22%-4%-6%-4%-4%
ROA--13%-25%-6%-11%-14%-14%
ROE-21%-37%-10%-40%-55%-55%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201912/202012/202112/202212/202312/2024TTM
Debt over FCF--1.23-0.35-0.33-0.26-0.49-0.49
Debt over Equity--0.240.050.050.070.070.07
Growth Stability------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-53%50%48%59%40%50%
Earnings YoY growth--79%577%-74%146%-1%-
Equity YoY growth-23%-483%-5%-36%-29%-20%
FCF YoY growth--48%181%-5%18%-59%-